SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

FDA Approves Additional Data for Cytokinetics’ Myqorzo NDA

Cytokinetics said the FDA approved including additional data in Myqorzo’s new drug application.

CYTK

Related stories